A Regulatory Perspective on Testing of Biological Activity of Complex Biologics
- 1 March 2018
- journal article
- editorial
- Published by Elsevier in Trends in Biotechnology
- Vol. 36 (3) , 231-234
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- “Two-in-One” approach for bioassay selection for dual specificity antibodiesJournal of Immunological Methods, 2017
- Next-Generation Antibody-Drug Conjugates (ADCs) for Cancer TherapyACS Medicinal Chemistry Letters, 2016
- Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?Antibodies, 2015
- Development and validation of a novel SPR-based assay principle for bispecific moleculesJournal of Pharmaceutical and Biomedical Analysis, 2015
- Trastuzumab emtansine: mechanisms of action and drug resistanceBreast Cancer Research, 2014
- Introduction to current and future protein therapeutics: A protein engineering perspectiveExperimental Cell Research, 2011
- Analytical methods for physicochemical characterization of antibody drug conjugatesmAbs, 2011